Related Experiment Video
Updated: Jul 8, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption
A Boschi1, C Tinelli, P Ortolani
1Division of Infectious Diseases, AUSL Rimini, Rimini, Italy. boschia@libero.it
Insights
Understanding factors that predict time to return to nadir CD4 count is crucial for repeated antiretroviral therapy (ART) interruptions. Younger age, lower pre-ART HIV RNA, and female gender predict longer recovery times, potentially improving clinical outcomes.
Area of Science:
- HIV/AIDS research
- Immunology
- Virology
Background:
- Previous studies indicate similar durations for initial and subsequent therapy interruptions (TI) in HIV management.
- Resuming antiretroviral therapy (ART) at or above the nadir CD4 count is key for consistent TI success.
- Identifying predictors for CD4 T-cell count return to nadir (TRN) is essential for optimizing repeated TI strategies.
Purpose of the Study:
- To identify factors that predict the time for CD4 T-cell count to return to nadir (TRN) in patients undergoing ART interruption.
- To understand the relationship between TRN and clinical events during repeated TI in HIV-positive individuals.
Main Methods:
- Analysis of a cohort of 92 patients who interrupted ART and reached a CD4 count similar to their nadir.
- Multivariate analysis to determine predictors of TRN.
Main Results:
- The median TRN was 12.3 months.
- Younger age, lower pre-ART HIV RNA levels, and female gender were significantly associated with a longer TRN (P=0.011, P=0.022, P=0.045, respectively).
- 11 clinical events occurred in patients with nadir CD4 >200 cells/µL, primarily during prolonged TI beyond TRN.
Conclusions:
- Age, pre-ART HIV RNA, and gender are significant predictors of TRN.
- Resuming ART when CD4 counts reach nadir levels appears protective against clinical events.
- The observational nature of the study limits definitive conclusions for clinical practice implementation.
Objective:
Our previous studies on CD4-guided therapy interruption (TI) showed that the durations of the first and second TIs were similar if antiretroviral therapy (ART) was resumed at a level of the CD4 cell count similar to or higher than the nadir CD4 T-cell count. Therefore, in a strategy of repeated CD4-guided TI, it is important to know which factors predict the time for the CD4 T-cell count to return to nadir (TRN).
Methods:
From a cohort of 125 patients who interrupted ART, 92 patients who reached a CD4 T-cell count similar to the nadir count were included in the study.
Results:
The median TRN was 12.3 months. In the multivariate analysis, younger age (P=0.011), lower pre-ART HIV RNA (P=0.022) and female gender (P=0.045) were associated with a longer TRN. After TI there were 11 clinical events in the group of patients whose nadir CD4 count was >200 cells/microL. Most of these events occurred when the TI was prolonged beyond the TRN.
Conclusions:
The factors predicting the TRN were age, HIV RNA pre-ART and gender. Resumption of therapy at a CD4 cell count similar to the nadir CD4 count appears to protect against the development of clinical events. Given the observational nature of this study, no conclusions can be drawn regarding the possible application of TI in clinical practice.
Related Concept Videos
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

